Schedule 13G ownership disclosure

ZYNERBA PHARMACEUTICALS INC

Security class unavailable · CUSIP: 98986X109

Event date: 2023-08-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,426,381
Percent of class
8.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-23-000608
Form type
SC 13G
Filer
Beryl Capital Management LLC
CIK
CIK 1719307
Filed
Sep 05, 2023
Reporting period
Aug 24, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub